Article

Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer

German Cancer Research Center, Division of Molecular Genome Analysis, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
Molecular Cancer (Impact Factor: 5.4). 12/2009; 8:130. DOI: 10.1186/1476-4598-8-130
Source: PubMed

ABSTRACT Despite recent progress in the identification of genetic and molecular alterations in prostate cancer, markers associated with tumor progression are scarce. Therefore precise diagnosis of patients and prognosis of the disease remain difficult. This study investigated novel molecular markers discriminating between low and highly aggressive types of prostate cancer.
Using 52 microdissected cell populations of low- and high-risk prostate tumors, we identified via global cDNA microarrays analysis almost 1200 genes being differentially expressed among these groups. These genes were analyzed by statistical, pathway and gene enrichment methods. Twenty selected candidate genes were verified by quantitative real time PCR and immunohistochemistry. In concordance with the mRNA levels, two genes MAP3K5 and PDIA3 exposed differential protein expression. Functional characterization of PDIA3 revealed a pro-apoptotic role of this gene in PC3 prostate cancer cells.
Our analyses provide deeper insights into the molecular changes occurring during prostate cancer progression. The genes MAP3K5 and PDIA3 are associated with malignant stages of prostate cancer and therefore provide novel potential biomarkers.

Download full-text

Full-text

Available from: Ruprecht Kuner, Oct 23, 2014
1 Follower
 · 
321 Views
  • Source
    • "Type 1 papillary renal tumor 3.4, 4.6 Ooi et al. (2011), Kort et al. (2008) Chromophobe renal tumor −7.9, −4.2, −6.4 Ooi et al. (2011), Kort et al. (2008), Yusenko et al. (2009) Oncocytoma −5.5, −5.6 Kort et al. (2008), Yusenko et al. (2009) Adrenal Adrenocortical carcinoma vs. normal adrenal cortex 5.7 Giordano et al. (2009) Pancreatic cancer Pancreatic cancer vs. matched normal tissue 2.9, 4.2, 5.4 Ishikawa et al. (2005), Pei et al. (2009), Donahue et al. (2012) Prostate cancer Mildly upregulated 1.3, 1.6 Pressinotti et al. (2009), Lapointe et al. (2004) Associated with progression Markert et al. (2011), Taylor et al. (2010) Ovarian cancer Serous ovarian tumors or tumor epithelial cells compared to normal −10 to −54 Shahab et al. (2011), King et al. (2011) AML CRNDE is one of 731 genes whose expression "
    [Show abstract] [Hide abstract]
    ABSTRACT: CRNDE is the gene symbol for Colorectal Neoplasia Differentially Expressed (non-protein-coding), a long non-coding RNA (lncRNA) gene that expresses multiple splice variants and displays a very tissue-specific pattern of expression. CRNDE was initially identified as a lncRNA whose expression is highly elevated in colorectal cancer, but it is also upregulated in many other solid tumors and in leukemias. Indeed, CRNDE is the most upregulated lncRNA in gliomas and here, as in other cancers, it is associated with a "stemness" signature. CRNDE is expressed in specific regions within the human and mouse brain; the mouse ortholog is high in induced pluripotent stem cells and increases further during neuronal differentiation. We suggest that CRNDE is a multifunctional lncRNA whose different splice forms provide specific functional scaffolds for regulatory complexes, such as the polycomb repressive complex 2 (PRC2) and CoREST chromatin-modifying complexes, which CRNDE helps pilot to target genes.
    Frontiers in Genetics 11/2012; 3:270. DOI:10.3389/fgene.2012.00270
  • Source
    • "Prostate cancer (correlation with malignity degree) [176] [177] [178] Erp57, Erp72, PDI P, I Chronic lymphocytic leukemia (with prolonged survival) and acute promyelocytic leukemia (methotrexate treatment) [179] [180] PDI, Erp57 P, I, G Breast cancer (in metastatic node vs primary tumors) [181] [182] [183] [184] [185] P5 I, G Hypoxia (in head and neck squamous cell line carcinoma) [186] Erp57 I Esophageal carcinoma (cells) [187] PDI P Oral squamous carcinoma (cells) [188] Erp57 P Gastric cancer [189] Erp46, Erp57 P, I Colorectal cancer (increases with 5-fluorouracil treatment) [190] [191] ER60 P, I Liver cancer (pheophorbide and photodynamic therapy in HepG2 cells) [192] Erp72, Erp57 P, I Hepatocellular carcinoma (increases in high vs low metastasis potential) [193] [194] Erp57, PDIp P Pancreatic carcinoma (increases in 5-aza-2′-deoxycytidine treatment) [195] [196] [197] PDI, Erp57, P5 P, I HeLa cells (resistance to aplidin) [198] PDI P, I H-RasV12-transformed p38α-deficient mouse embryo fibroblasts [199] Neurologic PDI, Erp57 P Hemiparkinson (in rat model) [200] Erp57 P Attention-deficit hyperactivity disorder (in midbrain and striatum, rat model) [201] PDI I Alzheimer disease (in temporal cortex brain) [202] PDI and Erp57 P, I Amyotrophic lateral sclerosis (in spinal cords from ALS patients vs controls, or G93A-SOD1 rat/mouse vs wild type) [203] [204] [205] Erp57 P Perinatal asphyxia (in hippocampus) [206] PDI I, G Brain ischemia (in dentate gyrus) [207] Erp57 P, I Sporadic Creutzfeldt-Jakob disease (in cerebellum) [208] Erp57 P Major depression (with paroxetine treatment) [209] PDI G Brain injury (with p-hydroxybenzyl alcohol treatment) [210] PDI P Tuberous sclerosis (HeLa cells transfected with TSC1/2 tumor suppressor gene) [211] Cardiovascular Erp57 P Endothelial function (improvement with salvianolic acid) [212] PDI P Acute coronary syndrome (in monocytes from atorvastatin-treated patients) [213] PDI I, G Ischemic heart disease (peri-infarct area vs remote area; murine HL-1 cells subjected to hypoxia vs control cells; MCP-1 Tg mice hearts vs wild type) [214] [215] PDI, Erp57, Erp44 P, I Preeclampsia (in placentae and trophoblasts) [216] [217] [218] Inflammation Erp46 I, G Varioliform gastritis [219] PDI P Antiphospholipid syndrome (with fluvastatin treatment) [220] Erp72 P Acute pancreatitis (in acinar cells) [221] Endocrine/metabolic Erp57 P, G Hepatosteatosis (in hepatic cells) [222] Erp57 P, G Obesity (subcutaneous adipose tissue in patients; white adipose tissue in leptin-treated ob/ob mice) [223] [224] PDI P, I Dyslipidemia (in fatty liver from high-fructose-fed hamsters) [225] Erp57 P, I Insulin resistance (in fat of obese subjects) [226] PDI, Erp57, P5 P, I Diabetes (in liver microsomes of diabetic rats; in islets exposed to high glucose) [227] [228] PDI P Insulin resistance and dyslipidemia (in hepatocytes) [229] Erp29, Erp72 I Congenital hypothyroid goiter (in thyroid tissues) [230] Others PDI P Hepatotoxicity (in carbon tetrachloride-induced liver injury) [231] ERP57 P, I Irritable bowel syndrome (in rat colon) [232] PDI P Helicobacter pylori infection (in gastric epithelial cells) [233] PDI P, I, G Smoker's lung [234] [235] Erp57 P, I Environmental contaminant (in nonylphenol-exposed Sertoli cells) [236] Erp57 P Periodontitis (in fibroblasts) [237] Erp57 P, I Dehydration (in rat hypothalamic supraoptic nucleus) [238] PDI, Erp57 P Aging (in colon epithelia and dermal fibroblasts) [239] [240] PDI I Pregnancy/embryo implantation (in decidualized endometrial lysates) [241] PDI P Episodic hypoxia (in rat kidney) [242] P, proteome analysis; I, immunodetection; G, gene expression analysis. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Thiol proteins may potentially act as redox signaling adaptor proteins, adjusting reactive oxygen species intermediates to specific signals and redox signals to cell homeostasis. In this review, we discuss redox effects of protein disulfide isomerase (PDI), a thioredoxin superfamily oxidoreductase from the endoplasmic reticulum (ER). Abundantly expressed PDI displays ubiquity, interactions with redox and nonredox proteins, versatile effects, and several posttranslational modifications. The PDI family contains >20 members with at least some apparent complementary actions. PDI has oxidoreductase, isomerase, and chaperone effects, the last not directly dependent on its thiols. PDI is a converging hub for pathways of disulfide bond introduction into ER-processed proteins, via hydrogen peroxide-generating mechanisms involving the oxidase Ero1α, as well as hydrogen peroxide-consuming reactions involving peroxiredoxin IV and the novel peroxidases Gpx7/8. PDI is a candidate pathway for coupling ER stress to oxidant generation. Emerging information suggests a convergence between PDI and Nox family NADPH oxidases. PDI silencing prevents Nox responses to angiotensin II and inhibits Akt phosphorylation in vascular cells and parasite phagocytosis in macrophages. PDI overexpression spontaneously enhances Nox activation and expression. In neutrophils, PDI redox-dependently associates with p47phox and supports the respiratory burst. At the cell surface, PDI exerts transnitrosation, thiol reductase, and apparent isomerase activities toward targets including adhesion and matrix proteins and proteases. Such effects mediate redox-dependent adhesion, coagulation/thrombosis, immune functions, and virus internalization. The route of PDI externalization remains elusive. Such multiple redox effects of PDI may contribute to its conspicuous expression and functional role in disease, rendering PDI family members putative redox cell signaling adaptors.
    Free Radical Biology and Medicine 03/2012; 52(9):1954-69. DOI:10.1016/j.freeradbiomed.2012.02.037 · 5.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Protein disulphide isomerase family A3 (PDIA3) is a member of the protein disulphide isomerase (PDI) family and is multifunctional in many processes. Recently, it has been confirmed as a sperm membrane component and is implicated in sperm-egg fusion under which the molecular mechanism is still obscure. Protein disulphide isomerase family A3 cDNA has been cloned in several mammals; however, goat and sheep counterparts have not been identified. To facilitate the studies on the potential function of PDIA3 protein in sperm-egg fusion in sheep and goat, we cloned the cDNA encoding for Pdia3 of sheep (Ovis aries) and cashmere goat (Capra hircus) and studied its transcript and protein localization in sheep testis. The cloned sheep and cashmere goat Pdia3 cDNA are 1660 bp and 1591 bp, respectively. Bioinformatics analysis showed that sheep and goat Pdia3 cDNA both have a coding region of 1518 bp with the same nucleotides encoding the same 505 amino acids. The predicted peptide, with two typical motifs of Trp-Cys-Gly-His-Cys-Lys (WCGHCK) which is a hallmark of the PDI family, has high homology to that of bovine (99.21%), human (95.05%), rat (89.50%) and mouse (90.89%). Protein disulphide isomerase family A3 protein was observed in cells of various stages of spermatogenesis, from the primary spermatocyte to spermatozoa phases, as well as in the Leydig cells. It was observed in the entire sheep spermatozoa and mostly at the equatorial segment and the forepart of the flagellum. The Pdia3 mRNA was detected over the seminiferous epithelium in all stages of spermatogenesis.
    Reproduction in Domestic Animals 03/2011; 46(6):980-9. DOI:10.1111/j.1439-0531.2011.01771.x · 1.18 Impact Factor
Show more